| Stacy Marie Atherton, DPM | |
|
1305 Sumner St, Ste 200, Longmont, CO 80501-3271 | |
| (303) 772-3232 | |
| Not Available |
| Full Name | Stacy Marie Atherton |
|---|---|
| Gender | Female |
| Speciality | Podiatry |
| Experience | 16 Years |
| Location | 1305 Sumner St, Longmont, Colorado |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1891957023 | NPI | - | NPPES |
| 78927528 | Medicaid | CO |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 213ES0103X | Podiatrist - Foot & Ankle Surgery | DP00437 (Oregon) | Secondary |
| 213ES0103X | Podiatrist - Foot & Ankle Surgery | 703 (Colorado) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Mckee Medical Center | Loveland, CO | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Foot And Ankle Center Of The Rockies Llc | 9931537693 | 10 |
News Archive
Edimer Pharmaceuticals, a biotechnology company focused on developing an innovative therapy for the rare genetic disorder X-linked Hypohidrotic Ectodermal Dysplasia (XLHED), today announced the enrollment and completed dosing of the first XLHED-affected neonate in a Phase 2 trial of EDI200, the company's novel, proprietary, recombinant protein.
During the WHO's recent executive board meeting, WHO Director-General Margaret Chan reflected on public health gains over the past decade and the challenges that lie ahead, Nigeria's Guardian reports. Chan commended the international community's response to H1N1 and global efforts to reduce child mortality, fight malaria and tuberculosis.
Scientists at the Barbara Ann Karmanos Cancer Institute in Detroit have received a nearly $3 million, five-year research project (RO1) grant from the National Institutes of Health to study a potentially ground-breaking immunotherapy treatment for women with one of the deadliest forms of breast cancer – triple-negative breast cancer. The research is exclusive to the Karmanos Cancer Institute.
A team of experts is predicting that the number of people suffering from dementia will double every 20 years and could reach more than 81 million worldwide by 2040.
An aggressive childhood brain tumor known as medulloblastoma originates in normal brain "stem" cells that turn malignant when acted on by a known mutant, cancer-causing oncogene, say researchers from Dana-Farber Cancer Institute and the University of California, San Francisco (UCSF).
› Verified 7 days ago
| Provider Name | Foot & Ankle Center Of Northern Colorado Pc |
|---|---|
| Provider Type | Part B Supplier - Clinic/group Practice |
| Provider Identifiers | NPI Number: 1770616567 PECOS PAC ID: 3577453711 Enrollment ID: O20040319000359 |
News Archive
Edimer Pharmaceuticals, a biotechnology company focused on developing an innovative therapy for the rare genetic disorder X-linked Hypohidrotic Ectodermal Dysplasia (XLHED), today announced the enrollment and completed dosing of the first XLHED-affected neonate in a Phase 2 trial of EDI200, the company's novel, proprietary, recombinant protein.
During the WHO's recent executive board meeting, WHO Director-General Margaret Chan reflected on public health gains over the past decade and the challenges that lie ahead, Nigeria's Guardian reports. Chan commended the international community's response to H1N1 and global efforts to reduce child mortality, fight malaria and tuberculosis.
Scientists at the Barbara Ann Karmanos Cancer Institute in Detroit have received a nearly $3 million, five-year research project (RO1) grant from the National Institutes of Health to study a potentially ground-breaking immunotherapy treatment for women with one of the deadliest forms of breast cancer – triple-negative breast cancer. The research is exclusive to the Karmanos Cancer Institute.
A team of experts is predicting that the number of people suffering from dementia will double every 20 years and could reach more than 81 million worldwide by 2040.
An aggressive childhood brain tumor known as medulloblastoma originates in normal brain "stem" cells that turn malignant when acted on by a known mutant, cancer-causing oncogene, say researchers from Dana-Farber Cancer Institute and the University of California, San Francisco (UCSF).
› Verified 7 days ago
| Provider Name | Foot And Ankle Center Of The Rockies Llc |
|---|---|
| Provider Type | Part B Supplier - Clinic/group Practice |
| Provider Identifiers | NPI Number: 1659831238 PECOS PAC ID: 9931537693 Enrollment ID: O20200312001227 |
News Archive
Edimer Pharmaceuticals, a biotechnology company focused on developing an innovative therapy for the rare genetic disorder X-linked Hypohidrotic Ectodermal Dysplasia (XLHED), today announced the enrollment and completed dosing of the first XLHED-affected neonate in a Phase 2 trial of EDI200, the company's novel, proprietary, recombinant protein.
During the WHO's recent executive board meeting, WHO Director-General Margaret Chan reflected on public health gains over the past decade and the challenges that lie ahead, Nigeria's Guardian reports. Chan commended the international community's response to H1N1 and global efforts to reduce child mortality, fight malaria and tuberculosis.
Scientists at the Barbara Ann Karmanos Cancer Institute in Detroit have received a nearly $3 million, five-year research project (RO1) grant from the National Institutes of Health to study a potentially ground-breaking immunotherapy treatment for women with one of the deadliest forms of breast cancer – triple-negative breast cancer. The research is exclusive to the Karmanos Cancer Institute.
A team of experts is predicting that the number of people suffering from dementia will double every 20 years and could reach more than 81 million worldwide by 2040.
An aggressive childhood brain tumor known as medulloblastoma originates in normal brain "stem" cells that turn malignant when acted on by a known mutant, cancer-causing oncogene, say researchers from Dana-Farber Cancer Institute and the University of California, San Francisco (UCSF).
› Verified 7 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Stacy Marie Atherton, DPM 1931 65th Ave, #a, Greeley, CO 80634-7945 Ph: (970) 351-0900 | Stacy Marie Atherton, DPM 1305 Sumner St, Ste 200, Longmont, CO 80501-3271 Ph: (303) 772-3232 |
News Archive
Edimer Pharmaceuticals, a biotechnology company focused on developing an innovative therapy for the rare genetic disorder X-linked Hypohidrotic Ectodermal Dysplasia (XLHED), today announced the enrollment and completed dosing of the first XLHED-affected neonate in a Phase 2 trial of EDI200, the company's novel, proprietary, recombinant protein.
During the WHO's recent executive board meeting, WHO Director-General Margaret Chan reflected on public health gains over the past decade and the challenges that lie ahead, Nigeria's Guardian reports. Chan commended the international community's response to H1N1 and global efforts to reduce child mortality, fight malaria and tuberculosis.
Scientists at the Barbara Ann Karmanos Cancer Institute in Detroit have received a nearly $3 million, five-year research project (RO1) grant from the National Institutes of Health to study a potentially ground-breaking immunotherapy treatment for women with one of the deadliest forms of breast cancer – triple-negative breast cancer. The research is exclusive to the Karmanos Cancer Institute.
A team of experts is predicting that the number of people suffering from dementia will double every 20 years and could reach more than 81 million worldwide by 2040.
An aggressive childhood brain tumor known as medulloblastoma originates in normal brain "stem" cells that turn malignant when acted on by a known mutant, cancer-causing oncogene, say researchers from Dana-Farber Cancer Institute and the University of California, San Francisco (UCSF).
› Verified 7 days ago
Foot And Ankle Center Of The Rockies Llc Podiatrist Medicare: Medicare Enrolled Practice Location: 1305 Sumner St Unit 200, Longmont, CO 80501 Phone: 303-772-3232 | |
Dr. Robert Matthew Smith, D.P.M, C.PED Podiatrist Medicare: May Accept Medicare Assignments Practice Location: 2030 Mountain View Ave, Suite 300, Longmont, CO 80501 Phone: 303-974-7474 Fax: 303-997-1085 | |
Mvfac Podiatrist Medicare: Not Enrolled in Medicare Practice Location: 1305 Sumner St, Ste 200, Longmont, CO 80501 Phone: 303-772-3232 Fax: 303-772-2360 | |
Altitude Foot & Ankle Center Podiatrist Medicare: Not Enrolled in Medicare Practice Location: 1138 Olympia Ave, Unit B, Longmont, CO 80504 Phone: 419-788-2396 | |
Dr. Kimberly Lynn Wilms, D.P.M. Podiatrist Medicare: Accepting Medicare Assignments Practice Location: 1138 Olympia Avenue, Unit B, Longmont, CO 80504 Phone: 419-788-2396 | |
Dr. James David Yakel, DPM Podiatrist Medicare: Accepting Medicare Assignments Practice Location: 1551 Professional Ln Unit 160, Longmont, CO 80501 Phone: 720-323-6678 | |
Colorado Foot & Ankle Clinic Podiatrist Medicare: Medicare Enrolled Practice Location: 2030 Mountain View Ave, Suite 300, Longmont, CO 80501 Phone: 303-974-7474 Fax: 303-997-1085 |